...S. Ramsey; G. Kerr; G.C.W. Howard; R. Donat Objective: To examine the outcome of orchidectomy following primary chemotherapy in patients with metastatic testicular cancer. Patients and Methods: This was a retrospective analysis of patients who underwent primary chemotherapy without initial...

... and toe before treatment versus 34% in the orchidectomy group. Despite the greater proportion of subclinical atherosclerotic disease in the legs of the patients in the orchidectomy group, the patients in the oestrogen group only had signs and symptoms of a deterioration of the arterial system. Thus...

...R. Tomić; J.-E. Damber Serum concentrations of testosterone, luteinizing hormone (LH) and follicle-stimulating hormone (FSH) were determined before and after orchidectomy performed at different intervals (2–29 months) after withdrawal of estrogen therapy in patients with prostatic carcinoma...

... cancer before treatment and after orchidectomy or during estrogen treatment (intramuscular polyestradiol phosphate during the first 3 months, followed by another 3 months with additional oral ethinyl estradiol). Orchidectomy as well as single drug intramuscular or oral + intramuscular estrogens exerted...

...B. Bergman; J.E. Damber; R. Tomić 22 men with carcinoma of the prostate were consecutively subjected to either total or subcapsular orchidectomy at random. Serum concentrations of testosterone, follicle-stimulating hormone, luteinizing hormone, prolactin, thyroid-stimulating hormone...